They control blood sugar, pain, mood, immunity, and hunger. GLP-1 is just one of them.

Science /
Explained
Understand how peptides work. The mechanism, the research, and the questions still open.
Your body has been making GLP-1 your whole life. Ozempic just makes the signal louder.

Salmon triggers one hormonal cascade. A candy bar triggers another. The gut reads every difference.


Insulin in 1921. Ozempic a century later. The research pattern is the same.
The 27 most-searched myths and worries about weight-loss peptides, read against the actual evidence.
- 1Some hair falls on GLP-1, and it grows back
- 2GLP-1 does not attack teeth, but the conditions around it can
- 3The evidence linking GLP-1 to erectile dysfunction is thin
- 4No clear mechanism ties GLP-1 to lower libido
- 5Ozempic face is fat loss, not the peptide aging your skin
- 6Loose skin follows the weight loss, not the peptide
- 7Some muscle goes with GLP-1, but fat falls faster
- 8GLP-1 does not strip vitamins, it cuts how much food comes in
- 9GLP-1 does not dry you out, eating and drinking less around it can
- 10Constipation is one of the most common GLP-1 side effects
- 11Nausea is common and expected, especially while the dose climbs
- 12Slower stomach emptying is how GLP-1 works, paralysis overstates it
- 13The kidney risk runs through dehydration from severe GI symptoms
- 14Direct liver injury is not a primary GLP-1 safety signal
- 15Gallbladder problems are a real risk, and so is fast weight loss
- 16Pancreatitis risk is real, and the absolute rate is low
- 17Human data show no clear thyroid-cancer signal, but the boxed warning stays
- 18FDA's 2026 review found no increased suicide risk across 91 trials
- 19Infertility is not an established GLP-1 risk, pregnancy timing is the real concern
- 20Tirzepatide affects oral birth control, semaglutide's label does not say so
- 21A rare optic-nerve signal exists, and the absolute rates are low
- 22About two-thirds of the lost weight returns after stopping
- 23GLP-1 does not wreck metabolism, weight loss slows it either way
- 24Weight-loss peptides are not addictive the way stimulants are
- 25The molecule is identical on paper, the supply chain is not
- 26A certificate of analysis is necessary, not sufficient
- 27Mild side effects are how the peptide works, not proof it is bad

What we know fills libraries. What we don't know fills the next decade of research.
- 1GLP-1 reaches brain circuits beyond appetite
- 2The same GLP-1 dose produces different results in different people
- 3Years on GLP-1 leave marks on the brain we are still mapping
- 4Lower maintenance doses may hold the weight after the loss
- 5GIP and glucagon add new levers the newest peptides pull
- 6Gut bacteria and GLP-1 run a two-way feedback loop

How pricing, sourcing, access, and brand actually connect, read as one system.

How to read COAs, purity, third-party testing, and traceability without taking words for proof.

The lived experience of starting a GLP-1, side by side with what the science says.



Science /
Explained
Understand how peptides work.
The mechanism, the research, and the questions still open.
They control blood sugar, pain, mood, immunity, and hunger. GLP-1 is just one of them.
Your body has been making GLP-1 your whole life. Ozempic just makes the signal louder.

Salmon triggers one hormonal cascade. A candy bar triggers another. The gut reads every difference.


Insulin in 1921. Ozempic a century later. The research pattern is the same.

The 27 most-searched myths and worries about weight-loss peptides, read against the actual evidence.
- 1Some hair falls on GLP-1, and it grows back
- 2GLP-1 does not attack teeth, but the conditions around it can
- 3The evidence linking GLP-1 to erectile dysfunction is thin
- 4No clear mechanism ties GLP-1 to lower libido
- 5Ozempic face is fat loss, not the peptide aging your skin
- 6Loose skin follows the weight loss, not the peptide
- 7Some muscle goes with GLP-1, but fat falls faster
- 8GLP-1 does not strip vitamins, it cuts how much food comes in
- 9GLP-1 does not dry you out, eating and drinking less around it can
- 10Constipation is one of the most common GLP-1 side effects
- 11Nausea is common and expected, especially while the dose climbs
- 12Slower stomach emptying is how GLP-1 works, paralysis overstates it
- 13The kidney risk runs through dehydration from severe GI symptoms
- 14Direct liver injury is not a primary GLP-1 safety signal
- 15Gallbladder problems are a real risk, and so is fast weight loss
- 16Pancreatitis risk is real, and the absolute rate is low
- 17Human data show no clear thyroid-cancer signal, but the boxed warning stays
- 18FDA's 2026 review found no increased suicide risk across 91 trials
- 19Infertility is not an established GLP-1 risk, pregnancy timing is the real concern
- 20Tirzepatide affects oral birth control, semaglutide's label does not say so
- 21A rare optic-nerve signal exists, and the absolute rates are low
- 22About two-thirds of the lost weight returns after stopping
- 23GLP-1 does not wreck metabolism, weight loss slows it either way
- 24Weight-loss peptides are not addictive the way stimulants are
- 25The molecule is identical on paper, the supply chain is not
- 26A certificate of analysis is necessary, not sufficient
- 27Mild side effects are how the peptide works, not proof it is bad

What we know fills libraries. What we don't know fills the next decade of research.
- 1GLP-1 reaches brain circuits beyond appetite
- 2The same GLP-1 dose produces different results in different people
- 3Years on GLP-1 leave marks on the brain we are still mapping
- 4Lower maintenance doses may hold the weight after the loss
- 5GIP and glucagon add new levers the newest peptides pull
- 6Gut bacteria and GLP-1 run a two-way feedback loop

How pricing, sourcing, access, and brand actually connect, read as one system.

How to read COAs, purity, third-party testing, and traceability without taking words for proof.

The lived experience of starting a GLP-1, side by side with what the science says.
